Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Bruce Johnson, MD, from Dana-Farber Cancer Institute, Boston, MA, explains the challenges associated with developing clinical trials for patients with rarer solid tumors, including defining subgroups of patients for specific therapeutic approaches and recruiting sufficient numbers of participants. Recorded at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO).